JOAQUÍN
MARTÍNEZ LÓPEZ
Catedrático de universidad
Ghent University
Gante, BélgicaGhent University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 18, pp. 1959-1970